Bristol-Myers Squibb Company
Location
New Jersey
Founded
1887-04-10
Website
Risk Signals
10470 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Bristol-Myers Squibb Company
Live alerts from global media, monitored by Business Radar
2025-03-04 (trefis.com)
Why Bristol Myers Squibb Stock Didn't Ride The Market Wave? |
Bristol Myers Squibb stock (NYSE: BMY) has gained 7% this year, outperforming the S&P 500 which has declined 1%. BMS's strong Q4 performance has helped drive its positive momentum. While markets broadly face pressure from new U.S. tariffs on Canada, Mexico, and China, investors are seeking defensive positions amid economic uncertainty.
Read more
2024-10-28 (healthtalk.no)
The industry reacts to errors in tenders: - Surprising and worrying
Several pharmaceutical companies participating in the ongoing TNF-BIO tender express strong concerns about an error that was made in the tender ranking. Several react particularly to the lack of communication from Hospital Purchasing.
Read more
2024-06-01 (tempo.co)
Sumber Sari Village, East Kalimantan, the latest food barn threatened by mining exploration
Residents of Sumber Sari Village, Kutai, East Kalimantan are threatened by mining exploration. During this time it has been a food barn and supplier of vegetables.
Read more
2024-05-25 (maghrebemergent.com)
Algeria BMS: notable increase in temperatures in various regions
Algeria is currently experiencing a significant rise in temperatures in several of its regions. This notable increase, which affects various areas of the country, causes concern and poses many challenges.
Read more
2024-03-26 (novomomento.com.br)
Sprycel drug for leukemia is at risk - Novo Momento
(SBTMO) publicize their concern regarding the shortage of the drug Sprycel® (dasatinib) in 20mg and 100mg presentations.
Read more
2023-10-26 (windsorstar.com)
Bond Yields Drop as Traders Pare Fed-Hike Wagers: Markets Wrap
Treasury yields fell as the latest economic reports did little to alter bets on a Federal Reserve pause next week. The euro remained lower after the European...
Read more
2023-06-28 (mikrocontroller.net)
13s Beams Am 12s Aku
Hello, I have the following concern. I have a 13S-3P battery. Now the problem is that the ESC that is supposed to be there can't handle 13S batteries and I now have to convert the battery from 12S. Which isn't a problem at first. The problem is that I don't see any suitable BMS for 12S Li-ion batteries with 44.4V on the internet
Read more
2023-06-16 (acento.com.do)
Bristol Myers Squibb will close one of its manufacturing plants in Puerto Rico
This closure, which will affect about 400 employees, has caused surprise and concern on the island.
Read more
2022-11-05 (nbcdfw.com)
Stability in a Volatile Market? Inside an S&P 500 ETF Delivering Double-Digit Percentage Dividends
The JPMorgan Equity Premium Income ETF seeks to provide the majority of returns associated with the S&P 500 even in times of high market uncertainty.
Read more
2022-06-29 (wfmz.com)
Artax Biopharma Appoints D. Scott Batty, Jr., M.D. as Chief Medical Officer
Here's a look at our top stories Wednesday morning. For more, watch 69 News or go to WFMZ.com
Read more
2022-06-29 (wfmz.com)
Artax Biopharma Appoints D. Scott Batty, Jr., M.D. as Chief Medical Officer
Here's a look at our top stories Wednesday morning. For more, watch 69 News or go to WFMZ.com
Read more
2022-05-13 (bioprocessintl.com)
CAR-Ts marred by auto- limitations, Allogene - BioProcess Insider
Autologous therapies have not kept up with demand says Allogene, which claims off-the-shelf cell therapies can serve larger populations.
Read more